scispace - formally typeset
C

Christian Götting

Researcher at Ruhr University Bochum

Publications -  109
Citations -  4610

Christian Götting is an academic researcher from Ruhr University Bochum. The author has contributed to research in topics: Xylosyltransferase & Pseudoxanthoma elasticum. The author has an hindex of 35, co-authored 109 publications receiving 4349 citations. Previous affiliations of Christian Götting include Heart and Diabetes Center North Rhine-Westphalia.

Papers
More filters
Journal ArticleDOI

Vitamin D supplementation enhances the beneficial effects of weight loss on cardiovascular disease risk markers

TL;DR: The results indicate that a vitamin D supplement of 83 microg/d does not adversely affect weight loss and is able to significantly improve several cardiovascular disease risk markers in overweight subjects with inadequate vitamin D status participating in a weight-reduction program.
Journal ArticleDOI

Molecular Cloning and Expression of Human UDP-d-Xylose:Proteoglycan Core Protein β-d-Xylosyltransferase and its First Isoform XT-II

TL;DR: RT-PCR analyses of XT-I and XT-II transcripts are ubiquitously expressed in the human tissues, although with different levels of transcription, and this enzyme belongs to a novel family of glycosyltransferases with no homology to proteins known so far.
Journal ArticleDOI

Effects of low- and high-advanced glycation endproduct meals on macro- and microvascular endothelial function and oxidative stress in patients with type 2 diabetes mellitus

TL;DR: In patients with T2DM, a HAGE meal induces a more pronounced acute impairment of vascular function than does an otherwise identical LAGE meal, suggesting chemical modifications of food by means of cooking play a major role in influencing the extent of postprandial vascular dysfunction.
Journal ArticleDOI

Pseudoxanthoma elasticum: genetics, clinical manifestations and therapeutic approaches.

TL;DR: Different therapeutic strategies to treat retinal manifestations are discussed, including thermal laser coagulation, photodynamic therapy, and intravitreal injections of drugs inhibiting vascular endothelial growth factor.